Drug resistance pattern and associated risk factors of tuberculosis patients in the central province of iran

Caspian Journal of Internal Medicine

Volumn 4, Issue 4, 2013, Pages 785-789

  Farazi, Aliasghar ^a   Sofian, Masoomeh ^a   Zarrinfar, Nader ^a   Katebi, Fatemeh ^a   Hoseini, Seyed Davood ^b   Keshavarz, Roohollah ^b  

^a ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b RAZI VACCINE AND SERUM RESEARCH INSTITUTE   (Iran)

Author keywords

Drug resistance; Mycobacterium tuberculosis; Risk factor

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; IRAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SPUTUM SMEAR; TUBERCULIN TEST;

EID: 84886784109     PISSN: 20086164     EISSN: 20086172     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Maartens G, Wilkinson RJ. Tuberculosis. Lancet 2007; 370: 2030-43.
2. Bwanga F, Hoffner S, Haile M, Joloba ML. Direct susceptibility testing for multidrug resistant tuberculosis: a meta-analysis. BMC Infect Dis 2009; 9: 67.
3. Kant S, Maurya AK, Kushwaha RA, Nag VL, Prasad R. Multi-drug resistant tuberculosis: an iatrogenic problem. Biosci Trends 2010; 4: 48-55.
4. Yew WW, Leung CC. Management of multidrug-resistant tuberculosis: Update 2007. Respirology 2008; 13: 21-46.
5. Chiang CY, Schaaf HS. Management of drug-resistant tuberculosis. Int J Tuberc Lung Dis 2010; 14: 672-82.
6. Aziz MA, Wright A, Laszlo A, et al. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet 2006; 368: 2142-54.
7. Farazi A, Jabbariasl M, Sofian M. Assessment of drug resistance in tuberculosis patients and the factors affecting it (2005-2010). Arak Med Univ J (AMUJ) 2012; 15: 77-85 [In Persian]
8. Anti-tuberculosis drug resistance in the world. Report No. 4. Availible at: URL: http://whqlibdoc.who.int/hq/2008/Who_Htm_TB_2008.394_eng.pdf
9. Guidelines for surveillance of drug resistance in tuberculosis Availible at:URL: http://www.who.int/tb/publications/mdr-surveillance/en/index.html
10. Burki T. Tuberculosis-resistance, funding, and drugs. Lancet Infect Dis 2010; 10: 297-8.
11. Wright A, Zignol M, Van Deun A, et al. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 2009; 373:1861-73.
12. Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax 2006; 61:158-63.
13. Law WS, Yew WW, Chiu C, et al. Risk factors for multidrug-resistant tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2008; 12: 1065-70.
14. Multidrug and extensively drug-resistant TB (M/XDR-TB). 2010 global report on surveillance and response. Availible at: http://whqlibdoc.who.int/publications/2010/9789241599191_eng.pdf
15. Suarez-Garcia I, Rodriguez-Blanco A, Vidal-Perez JL, et al. Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain. Eur J Clin Microbiol Infect Dis 2009; 28: 325-30.
16. Merza MA, Farnia P, Tabarsi P, et al. Anti-tuberculosis drug resistance and associated risk factors in a tertiary level TB centre in Iran: a retrospective analysis. J Infect Dev Ctries 2011; 5: 511-9.
17. Shamaei M, Marjani M, Chitsaz E, et al. First line antituberculosis drug resistant pattern and trends at the national TB referral center in Iran-eight years of surveillance. Int J Infect Dis 2009; 13: e236-40.
18. Mirsaeidi MS, Tabarsi P, Farnia P, et al. Trends of drug resistant mycobacterium tuberculosis in a tertiary tuberculous center in Iran. Saudi Med J 2007; 28: 544-50.
19. Baghaei P, Tabarsi P, Chitsaz E, et al. Risk Factors Associated with Multidrug-Resistant Tuberculosis. Tanaffos 2009; 8: 17-21.
20. Zignol M, Wright A, Jaramillo E, Nunn P, Raviglione MC. Patients with previously treated tuberculosis no longer neglected. Clin Infect Dis 2007; 44: 61-4.
21. Gao Q, Li X. Transmission of MDR tuberculosis. Drug Discov Today Dis Mech 2010; 7: e61-5.
22. BorgdorffMW, Small PM. Scratching the surface of ignorance on MDR tuberculosis. Lancet 2009; 373: 1822-4.